Aragen, Skyhawk partner to develop small molecule therapeutics that correct RNA expression
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.
July 16, 2021
by expresspharma
Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance
Will leverage SkySTAR platform to discover and develop small molecule treatments for oncology and neurological disease targets.
July 17, 2019
by contractpharma
Skyhawk, Biogen Expand Alliance in Neurological Disorders
Skyhawk receives an upfront payment and is eligible for future milestones and royalties.
July 9, 2019
by contractpharma
Skyhawk, Takeda to Develop Neurological Disease Targets
Skyhawk will use its SkySTAR platform to discover and develop small molecule treatments.
May 16, 2019
by contractpharma
Takeda taps Skyhawk's RNA-targeting tech for neurodegenerative disease
RNA biotech Skyhawk Therapeutics is inking another R&D deal—this time, it’s with Takeda Pharmaceutical, which wants to use the biotech’s platform to develop small molecules that correct RNA mis-splicing in neurodegenerative disease.
May 12, 2019
by fiercepharma
Skyhawk and Takeda partner to develop small molecule drugs
US-based Skyhawk Therapeutics has formed a strategic alliance with Takeda Pharmaceutical to discover and develop small molecule drug candidates for multiple targets across neurodegenerative diseases.
May 8, 2019
by pharmaceutical-technology
Skyhawk, Celgene in Strategic Discovery and Development Pact
Skyhawk Therapeutics, Inc. has entered a global, five-year strategic collaboration with Celgene Corp. to discover, develop and commercialize innovative small molecule treatments for patients with neurological diseases based on Skyhawk's STAR technology pl
July 3, 2018
by contractpharma
Celgene and Skyhawk initiate five-year collaboration for neurological diseases
Celgene has entered into a five-year global strategic collaboration with drug discovery and development company Skyhawk Therapeutics with an upfront payment of $60m
June 28, 2018
by pharmaceutical-technology